Key statistics
On Friday, Gyre Therapeutics Inc (GYRE:NAQ) closed at 14.03, 192.29% above the 52 week low of 4.80 set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.27 |
---|---|
High | 14.47 |
Low | 13.46 |
Bid | 11.15 |
Offer | 14.85 |
Previous close | 14.33 |
Average volume | 93.95k |
---|---|
Shares outstanding | 93.42m |
Free float | 23.53m |
P/E (TTM) | -- |
Market cap | 1.31bn USD |
EPS (TTM) | -0.8638 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
- Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
- Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
- Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
- Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
- Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
- Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
- Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
- Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
More ▼